Evaxion Biotech A/S (EVAX) ADR Each Representing 50 Ord Shares SPON

Sell:$3.08Buy:$3.10$0.87 (36.25%)

Prices delayed by at least 15 minutes
Sell:$3.08
Buy:$3.10
Change:$0.87 (36.25%)
Deal now
Prices delayed by at least 15 minutes
Sell:$3.08
Buy:$3.10
Change:$0.87 (36.25%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Key people

Click to see more

Key facts

  • EPIC
    -
  • Location
    Denmark
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US29970R3030
  • Market cap
    $2.82m
  • Employees
    49
  • Shares in issue
    0.00
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.